EcoDrugPlus

Estrogen Receptor 1

Ensembl ID : ENSPKIG00000018298
Gene Symbol: ESR1
1 Cross references
215 Possible Orthologues:

Estrogen Receptor 2a

Ensembl ID : ENSPKIG00000019208
Gene Symbol: ESR2A
1 Cross references
198 Possible Orthologues:

Estrogen Receptor 2b

Ensembl ID : ENSPKIG00000018813
Gene Symbol: ESR2B
1 Cross references
210 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSPKIG00000017623
Gene Symbol: ESRRG
3 Cross references
266 Possible Orthologues:

Estrogen-Related Receptor Gamma A

Ensembl ID : ENSPKIG00000004225
Gene Symbol: ESRRGA
1 Cross references
266 Possible Orthologues:

Exportin 1

Ensembl ID : ENSPKIG00000005688
Gene Symbol: XPO1
3 Cross references
145 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSPKIG00000014612
Gene Symbol: FDPS
3 Cross references
267 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSPKIG00000004839
Gene Symbol: FDFT1
3 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSPKIG00000014735
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSPKIG00000015297
Gene Symbol: FGFR1
3 Cross references
213 Possible Orthologues:

Fibroblast Growth Factor Receptor 1a

Ensembl ID : ENSPKIG00000024774
Gene Symbol: FGFR1A
2 Cross references
204 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSPKIG00000021449
Gene Symbol: FGFR2
1 Cross references
219 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).